However, another study reported that ACE2 activity in the mid-frontal cortex was significantly reduced in AD compared with age-matched controls and correlated inversely with levels of Aβ and phosphorylated tau (p-tau) pathology (Kehoe et al., 2016). The gene discussed is ACE2; the disease is Alzheimer disease.